Bear market hits another biotech as RedHill Biopharma lays off a third of US salesforce
As the biotech bear market continues its relentless beatdown of the sector, another company is feeling the heat and laying off staff.
The Israeli/North Carolina …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.